T. Yasuda

Variants associated with Gaucher disease in multiple system atrophy

J. Trojanowski, S. Gilman, Y. Kuroiwa, 2015, Annals of clinical and translational neurology.

Randomized, double‐blind, placebo‐controlled phase 1 study to evaluate the safety and pharmacokinetics of high doses of ubiquinol in healthy adults

T. Matsukawa, H. Ishiura, J. Mitsui, 2021, Neurology and Clinical Neuroscience.

Oxygen consumption rate for evaluation of COQ2 variants associated with multiple system atrophy

T. Matsukawa, S. Tsuji, J. Mitsui, 2019, neurogenetics.

Plasma Coenzyme Q10 Levels in Patients With Multiple System Atrophy.

T. Matsukawa, S. Tsuji, H. Ishiura, 2016, JAMA neurology.

Three-Year Follow-Up of High-Dose Ubiquinol Supplementation in a Case of Familial Multiple System Atrophy with Compound Heterozygous COQ2 Mutations

T. Matsukawa, S. Tsuji, T. Momose, 2017, The Cerebellum.

Genome-wide association study identifies a new susceptibility locus in PLA2G4C for Multiple System Atrophy.

Sonja W. Scholz, A. Singleton, Y. Kusakabe, 2023, medRxiv.

Oxygen consumption rate for evaluation of COQ2 variants associated with multiple system atrophy

T. Matsukawa, S. Tsuji, J. Mitsui, 2019, Neurogenetics.